JP2023500387A5 - - Google Patents

Info

Publication number
JP2023500387A5
JP2023500387A5 JP2022526794A JP2022526794A JP2023500387A5 JP 2023500387 A5 JP2023500387 A5 JP 2023500387A5 JP 2022526794 A JP2022526794 A JP 2022526794A JP 2022526794 A JP2022526794 A JP 2022526794A JP 2023500387 A5 JP2023500387 A5 JP 2023500387A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
variable region
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022526794A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023500387A (ja
JP7689955B2 (ja
Filing date
Publication date
Priority claimed from CN201911095151.9A external-priority patent/CN112778413B/zh
Application filed filed Critical
Publication of JP2023500387A publication Critical patent/JP2023500387A/ja
Publication of JP2023500387A5 publication Critical patent/JP2023500387A5/ja
Application granted granted Critical
Publication of JP7689955B2 publication Critical patent/JP7689955B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022526794A 2019-11-11 2020-11-03 抗水痘帯状疱疹ウイルス抗体 Active JP7689955B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201911095151.9A CN112778413B (zh) 2019-11-11 2019-11-11 抗水痘-带状疱疹病毒的抗体
CN201911095151.9 2019-11-11
PCT/CN2020/126159 WO2021093639A1 (zh) 2019-11-11 2020-11-03 抗水痘-带状疱疹病毒的抗体

Publications (3)

Publication Number Publication Date
JP2023500387A JP2023500387A (ja) 2023-01-05
JP2023500387A5 true JP2023500387A5 (enExample) 2023-06-23
JP7689955B2 JP7689955B2 (ja) 2025-06-09

Family

ID=75749734

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022526794A Active JP7689955B2 (ja) 2019-11-11 2020-11-03 抗水痘帯状疱疹ウイルス抗体

Country Status (6)

Country Link
US (1) US12491386B2 (enExample)
EP (1) EP4063383A4 (enExample)
JP (1) JP7689955B2 (enExample)
CN (5) CN117106070B (enExample)
PH (1) PH12022551151A1 (enExample)
WO (1) WO2021093639A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117106070B (zh) * 2019-11-11 2024-06-11 珠海泰诺麦博制药股份有限公司 抗水痘-带状疱疹病毒的抗体
CN117683121B (zh) * 2024-01-30 2024-04-16 北京百普赛斯生物科技股份有限公司 抗水痘-带状疱疹病毒抗体及其应用
CN119192349A (zh) * 2024-07-18 2024-12-27 北京市延庆区疾病预防控制中心 用于检测黄连素抗性病毒的试剂及方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2652959B2 (ja) * 1987-12-15 1997-09-10 東燃料株式会社 水痘・帯状疱疹ウイルス感染症の検出薬及び検出方法
US7018809B1 (en) 1991-09-19 2006-03-28 Genentech, Inc. Expression of functional antibody fragments
WO1995031546A1 (en) 1994-04-28 1995-11-23 Scotgen Biopharmaceuticals, Inc. Recombinant human anti-varicella zoster virus antibodies
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
US6528066B1 (en) * 1999-09-14 2003-03-04 University Of Iowa Research Foundation Variant varicella-zoster viruses and methods of use
BRPI0807084A2 (pt) * 2007-02-06 2014-04-29 Ribovax Biotechnologies Sa Anticorpos específicos para o virus varicela zoster
CN102517302A (zh) * 2011-12-28 2012-06-27 中国人民解放军军事医学科学院野战输血研究所 一种重组表达水痘-带状疱疹病毒截短型糖蛋白e的方法及其应用
CN104513813A (zh) * 2013-09-29 2015-04-15 上海满益科技有限公司 一种带状疱疹病毒的制备方法
KR101481362B1 (ko) * 2014-01-28 2015-01-15 연세대학교 원주산학협력단 수두대상포진 바이러스의 당단백질e를 발현하는 인간 세포를 이용한 수두대상포진 바이러스에 대한 면역력 진단 방법
CN105669838B (zh) * 2014-12-04 2020-10-16 厦门大学 来自水痘-带状疱疹病毒gE蛋白的中和表位及针对其的抗体
JP6367783B2 (ja) * 2015-11-26 2018-08-01 田中貴金属工業株式会社 水痘帯状疱疹ウイルス検出用免疫クロマト分析装置
CN106279378B (zh) * 2016-08-05 2018-06-19 北京市华信行生物科技有限公司 水痘带状疱疹病毒gE抗原及其在检测抗水痘带状疱疹病毒抗体中的用途
KR102028463B1 (ko) * 2016-11-25 2019-10-04 재단법인 목암생명과학연구소 바리셀라 조스터 바이러스 백신
CN107760690B (zh) * 2017-10-25 2018-08-28 珠海泰诺麦博生物技术有限公司 一种高通量全人源抗体的制备方法及应用
US11147870B2 (en) * 2018-04-25 2021-10-19 Emory University Specific binding agents to varicella-zoster virus and uses related thereto
CN109085354B (zh) * 2018-07-25 2021-07-23 武汉生命科技股份有限公司 水痘-带状疱疹病毒中和抗体的检测试剂盒及其检测方法
CN117106070B (zh) * 2019-11-11 2024-06-11 珠海泰诺麦博制药股份有限公司 抗水痘-带状疱疹病毒的抗体

Similar Documents

Publication Publication Date Title
CN113563475B (zh) 一种抗新型冠状病毒的双特异性抗体及其应用
ES2539751T3 (es) Anticuerpo monoclonal capaz de unirse con epítopo discontinuo específico que aparece en la región AD1 de la glucoproteína gB de citomegalovirus humano, y fragmento de unión a antígeno del mismo
CN106519034A (zh) 抗pd‑1抗体及其用途
JP2021515566A5 (enExample)
JP7527386B2 (ja) 新型コロナウイルスのヒトモノクローナル抗体およびその使用
JP2023500387A5 (enExample)
JP2014524902A5 (enExample)
JP2022550243A5 (enExample)
AU2019233507B2 (en) Treatment of head and neck cancer
CN115819592A (zh) 靶向ror1的抗原结合蛋白
CN114621343B (zh) 乙型脑炎病毒抗体2g1及其应用
CA3245425A1 (en) ANTIBODY-DRUG CONJUGATES COMPRISING STING AGONISTS, COMBINATIONS AND METHODS OF USE
JP2023553210A5 (enExample)
JP2009544574A5 (enExample)
CN115957321A (zh) 一种抗her2抗体在制备治疗癌症的药物中的用途
CN115894691A (zh) 靶向ror1的抗原结合蛋白
KR102937383B1 (ko) 개파보바이러스 특이적 항체 cpv-b3 및 이를 포함하는 개파보바이러스 감염증 치료용 약제학적 조성물
WO2024183622A1 (zh) 一种抗her2抗体在制备治疗癌症的药物中的用途
CN118076641A (zh) 抗cd26抗体及其应用
KR102934959B1 (ko) 개파보바이러스 특이적 항체 cpv-f12 및 이를 포함하는 개파보바이러스 감염증 치료용 약제학적 조성물
CN106963950B (zh) 用于治疗肿瘤的联合用药物
RU2024102201A (ru) Антитело b7h6 и его применение
CN107286237A (zh) 一种抗丙型肝炎病毒抗体的获取以及应用
HK40055435B (en) A bispecific antibody against novel coronavirus and its application
HK40055435A (en) A bispecific antibody against novel coronavirus and its application